We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
(+13%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
18.39%
Top 10 Holdings %
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$34.6M |
| 2 |
Workday
WDAY
|
+$33.5M |
| 3 |
FRC
First Republic Bank
FRC
|
+$31.8M |
| 4 |
Zoetis
ZTS
|
+$31.3M |
| 5 |
Synchrony
SYF
|
+$31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$35.7M |
| 2 |
Honeywell
HON
|
+$31.7M |
| 3 |
International Paper
IP
|
+$30.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$23.8M |
| 5 |
Emerson Electric
EMR
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.12% |
| 2 | Financials | 17.75% |
| 3 | Healthcare | 12.17% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Fulcrum Therapeutics
FULC
$282M
| $257K | ﹤0.01% |
10,887
-14,037
| -56% | -$199K |
|
|
MTOR
2927
DELISTED
MERITOR, Inc.
MTOR
| $257K | ﹤0.01% |
7,223
-107,104
| -94% | -$3.17M |
|
2928
AtriCure
ATRC
$2.18B
| $256K | ﹤0.01% |
3,905
-13,534
| -78% | -$877K |
|
|
SMAPU
2929
DELISTED
SportsMap Tech Acquisition Corp. Units
SMAPU
| $256K | ﹤0.01% |
25,442
-1
| -0% | -$10 |
|
2930
Hyster-Yale Materials Handling
HY
$619M
| $255K | ﹤0.01% |
+7,679
| New | +$304K |
|
|
STR
2931
DELISTED
Sitio Royalties
STR
| $255K | ﹤0.01% |
9,456
-4,626
| -33% | -$104K |
|
2932
Unisys
UIS
$205M
| $255K | ﹤0.01% |
+11,783
| New | +$239K |
|
|
KLR
2933
DELISTED
Kaleyra, Inc.
KLR
| $255K | ﹤0.01% |
+12,186
| New | +$339K |
|
|
AMWD
2934
DELISTED
American Woodmark
AMWD
| $254K | ﹤0.01% |
5,188
-856
| -14% | -$49.2K |
|
2935
Ardelyx
ARDX
$982M
| $253K | ﹤0.01% |
236,389
-365,411
| -61% | -$326K |
|
|
NEXN
2936
Nexxen International
NEXN
$584M
| $253K | ﹤0.01% |
16,646
+4,384
| +36% | +$63.2K |
|
2937
First Internet Bancorp
INBK
$256M
| $252K | ﹤0.01% |
5,866
+615
| +12% | +$29.8K |
|
2938
Nomad Foods
NOMD
$1.59B
| $252K | ﹤0.01% |
11,160
-19,585
| -64% | -$476K |
|
2939
TransUnion
TRU
$15.4B
| $252K | ﹤0.01% |
2,441
-44,755
| -95% | -$4.54M |
|
2940
Chefs' Warehouse
CHEF
$4.46B
| $251K | ﹤0.01% |
7,702
-62,109
| -89% | -$1.95M |
|
2941
Standard Motor Products
SMP
$889M
| $251K | ﹤0.01% |
5,815
-4,108
| -41% | -$193K |
|
2942
Vertex
VERX
$1.98B
| $251K | ﹤0.01% |
16,341
-6,235
| -28% | -$87.2K |
|
|
EWCZ
2943
DELISTED
European Wax Center
EWCZ
| $250K | ﹤0.01% |
+8,470
| New | +$220K |
|
|
CDAQ
2944
DELISTED
Compass Digital Acquisition Corp. Class A Ordinary Shares
CDAQ
| $250K | ﹤0.01% |
+25,913
| New | +$250K |
|
|
EBAC
2945
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
| $250K | ﹤0.01% |
+25,659
| New | +$249K |
|
|
TGA
2946
DELISTED
Transglobe Energy Corp
TGA
| $250K | ﹤0.01% |
+68,603
| New | +$233K |
|
|
CVII
2947
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $247K | ﹤0.01% |
+25,200
| New | +$246K |
|
2948
Agilon Health
AGL
$1.45B
| $246K | ﹤0.01% |
388
-306
| -44% | -$158K |
|
2949
Danaher
DHR
$146B
| $246K | ﹤0.01% |
946
-9,206
| -91% | -$2.31M |
|
2950
Lyell Immunopharma
LYEL
$365M
| $246K | ﹤0.01% |
2,440
-5,854
| -71% | -$709K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2022 Portfolio in Review
As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.
- Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
- Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
- Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
- Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
- Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
- Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
- Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.